Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

ME Therapeutics Holdings (CN:METX) Gains Momentum as Immuno-Oncology Pipeline Supports Investor Optimism

ME Therapeutics Holdings, Inc. is a Vancouver-based biotechnology company developing immuno-oncology therapies designed to reprogram or redirect immune cells inside the body to fight cancer. Its research is concentrated on in vivo chimeric antigen receptor technology and therapeutic mRNA approaches. The recent rise in …

Ankur Sharma | 28 September 2026

Vector Science and Therapeutics Corp. (TSXV:PAIN) Gains Momentum as Peptide Commercialization and Therapeutic Innovation Support Sentiment

Vector Science and Therapeutics Corp. is a healthcare technology and therapeutics company developing biomechanical devices, localized therapeutic delivery systems and peptide-based formulations. Its strategy is built around delivering treatments directly to targeted tissues where conventional systemic administration may create unwanted exposure or reduce therapeutic …

Ankur Sharma | 28 September 2026

Spectral Medical Inc. (TSX:EDT): Sepsis Treatment Innovation and Regulatory Progress Support Renewed Healthcare Sector Momentum

Spectral Medical Inc. (TSX:EDT) is a Canadian healthcare technology company focused on developing diagnostic and therapeutic solutions for critical-care medicine, particularly in the treatment of sepsis and septic shock. The company’s core platform combines its proprietary Endotoxin Activity Assay (EAA) diagnostic technology with Toraymyxin …

Ankur Sharma | 25 September 2026

Cannara Biotech Inc. (TSX:LOVE) Gains Momentum as Cannabis Expansion Strategy and Operational Growth Support Investor Confidence

Cannara Biotech Inc. (TSX:LOVE) is a Canadian vertically integrated cannabis company focused on producing premium-grade cannabis products and cannabis-derived offerings. The company operates large-scale cultivation facilities in Québec and develops branded products across multiple cannabis categories. ItsBusinessmodel combines cultivation, processing, product development and distribution …

Ankur Sharma | 25 September 2026

COSCIENS Biopharma Inc. (TSX:CSCI): Biopharma Transformation and Innovation Pipeline Support Renewed Investor Confidence

COSCIENS Biopharma Inc. (TSX:CSCI) is a Canadian biopharmaceutical company focused on developing and commercialising pharmaceutical products, diagnostic solutions and specialised active ingredients for healthcare and wellness markets. The company operates through businesses including Ceapro and Nualtis, combining expertise in natural ingredient technologies, biotechnology and …

Ankur Sharma | 25 September 2026

Arch Biopartners (TSXV:ARCH) Gains Momentum as Kidney Disease Pipeline Progress Fuels Healthcare Investor Interest

Arch Biopartners Inc. (TSXV:ARCH) is a clinical-stage biotechnology company focused on developing innovative treatments for kidney-related diseases and inflammatory conditions. The company’s stock gained market attention after rising and closing higher on 24 September 2026, increasing by 6.17% during the trading session.

Ankur Sharma | 25 September 2026

Grey Wolf Health Corp. (TSXV:WOLF) Gains Market Momentum as Healthcare Expansion Strategy Supports Growth Outlook

Grey Wolf Health Corp. (TSXV:WOLF) is a Canadian diversified healthcare company focused on developing and commercialising products that address unmet needs across human and animal health markets. The company has attracted renewed investor attention after its stock rose and closed higher on 24 September …

Ankur Sharma | 25 September 2026

BriaCell Therapeutics Corp. (TSX:BCT): Immunotherapy Pipeline Progress and Clinical Momentum Drive Renewed Investor Confidence

BriaCell Therapeutics Corp. (TSX:BCT) is a biotechnology company focused on developing novel immunotherapies designed to transform cancer treatment. The company’s pipeline is centred on immune-based therapies that aim to stimulate the body’s immune system to recognise and attack cancer cells. The recent share price …

Ankur Sharma | 25 September 2026

Burcon NutraScience Corporation (TSX:BU) Gains Momentum as Plant-Based Protein Growth Strategy Boosts Investor Confidence

Burcon NutraScience Corporation (TSX:BU) is a food technology company focused on developing and commercialising innovative plant-based protein ingredients for global food and beverage markets. The company has built a portfolio of protein technologies designed to address increasing demand for alternative nutrition solutions, including ingredients …

Ankur Sharma | 25 September 2026

Curaleaf Holdings Stock Drops 4.64% as Deal Uncertainty and Cannabis-Sector Volatility Pressure TSX:CURA

Curaleaf Holdings Inc. (TSX:CURA) is an international cannabis company with operations spanning cultivation, processing, branded consumer products, medical cannabis and retail distribution. Its portfolio includes Curaleaf, Select, Grassroots, Find and other brands, while its international network extends across Europe and other regulated markets. The …

Ankur Sharma | 25 September 2026
Support

Hi! How can we help you today?

Loading…